Brazil's A.C.Camargo Cancer Center Adopts Masimo SpHb for Noninvasive and Continuous Hemoglobin Monitoring

Masimo MASI announced today that A.C.Camargo Cancer Center in Sao Paulo, Brazil has installed Masimo's noninvasive and continuous hemoglobin (SpHb®) technology to monitor surgical patients. Clinicians use invasive blood sampling and laboratory analysis of hemoglobin to determine hemoglobin levels and help estimate blood loss to determine need for red blood cell transfusions. However, lab-based hemoglobin is only available intermittently and results are often delayed. SpHb offers real-time visibility to changes – or lack of changes – in hemoglobin between invasive blood sampling. "The data associating transfusion with higher mortality rates was clear, so we knew we had to implement strategies to reduce See full press release